<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Park DS</submitter><funding>NCI NIH HHS</funding><funding>National Research Foundation of Korea</funding><pagination>e48693</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7202204</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(5)</volume><pubmed_abstract>The tumor suppressor Smad4, a key mediator of the TGF-β/BMP pathways, is essential for development and tissue homeostasis. Phosphorylation of Smad4 in its linker region catalyzed by the mitogen-activated protein kinase (MAPK) plays a pivotal role in regulating its transcriptional activity and stability. In contrast, roles of Smad4 dephosphorylation as a control mechanism of TGF-β/BMP signaling and the phosphatases responsible for its dephosphorylation remain so far elusive. Here, we identify Wip1 as a Smad4 phosphatase. Wip1 selectively binds and dephosphorylates Smad4 at Thr277, a key MAPK phosphorylation site, thereby regulating its nuclear accumulation and half-life. In Xenopus embryos, Wip1 limits mesoderm formation and favors neural induction by inhibiting TGF-β/BMP signals. Wip1 restrains TGF-β-induced growth arrest, migration, and invasion in human cells and enhances the tumorigenicity of cancer cells by repressing the antimitogenic activity of Smad4. We propose that Wip1-dependent dephosphorylation of Smad4 is critical for the regulation of TGF-β signaling.</pubmed_abstract><journal>EMBO reports</journal><pubmed_title>Wip1 regulates Smad4 phosphorylation and inhibits TGF-β signaling.</pubmed_title><pmcid>PMC7202204</pmcid><funding_grant_id>2019R1H1A2080117</funding_grant_id><funding_grant_id>T32 CA009594</funding_grant_id><funding_grant_id>2016R1A2B4013355</funding_grant_id><pubmed_authors>Kim EY</pubmed_authors><pubmed_authors>Choi SC</pubmed_authors><pubmed_authors>Park DS</pubmed_authors><pubmed_authors>Kim K</pubmed_authors><pubmed_authors>Lee PC</pubmed_authors><pubmed_authors>Chang EJ</pubmed_authors><pubmed_authors>Lee T</pubmed_authors><pubmed_authors>Yoon GH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Wip1 regulates Smad4 phosphorylation and inhibits TGF-β signaling.</name><description>The tumor suppressor Smad4, a key mediator of the TGF-β/BMP pathways, is essential for development and tissue homeostasis. Phosphorylation of Smad4 in its linker region catalyzed by the mitogen-activated protein kinase (MAPK) plays a pivotal role in regulating its transcriptional activity and stability. In contrast, roles of Smad4 dephosphorylation as a control mechanism of TGF-β/BMP signaling and the phosphatases responsible for its dephosphorylation remain so far elusive. Here, we identify Wip1 as a Smad4 phosphatase. Wip1 selectively binds and dephosphorylates Smad4 at Thr277, a key MAPK phosphorylation site, thereby regulating its nuclear accumulation and half-life. In Xenopus embryos, Wip1 limits mesoderm formation and favors neural induction by inhibiting TGF-β/BMP signals. Wip1 restrains TGF-β-induced growth arrest, migration, and invasion in human cells and enhances the tumorigenicity of cancer cells by repressing the antimitogenic activity of Smad4. We propose that Wip1-dependent dephosphorylation of Smad4 is critical for the regulation of TGF-β signaling.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 May</publication><modification>2026-06-04T06:45:33.967Z</modification><creation>2025-02-19T03:40:43.97Z</creation></dates><accession>S-EPMC7202204</accession><cross_references><pubmed>32103600</pubmed><doi>10.15252/embr.201948693</doi></cross_references></HashMap>